Sort
30,917 grants matching “tumor microenvironment”
Targeting the Vascular System
$397,281Tracy T Batchelor · Massachusetts General Hospital · P50 · FY2015 · CA
Antagonistic role of ARF and ADAR1 in triple-negative breast cancer
$397,274Jason Weber · Washington University · R01 · FY2024 · CA
Cell lineage as an indicator of immune response in neuroblastoma
$397,270Rani E George · Dana-Farber Cancer Inst · R01 · FY2023 · CA
Exploiting Caveolae-Dependent Albumin Endocytosis to Optimize Therapy in Pancreatic Cancer
$397,192Terence Marques Williams · Ohio State University · R01 · FY2017 · CA
TLR5 signaling as a conserved mechanism of impaired anti-tumor immunity
$397,110Melanie R Rutkowski · University Of Virginia · R01 · FY2024 · CA
Neutralizing Stromal NetrinG1 to Intercept Pancreatic Cancer
$397,088Edna Cukierman · Research Inst Of Fox Chase Can Ctr · U54 · FY2024 · CA
Cancer Cell Intrinsic Interferon-I pathway Activation by Fractionated Radiation
$397,076Sandra Demaria · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA
The Role of ADAM15 in Prostate Tumor Intravazation and Metastasis
$397,075Mark L Day · University Of Michigan At Ann Arbor · R01 · FY2012 · CA
Mechanical Regulation of Tumor Angiogenesis
$397,073Cynthia A Reinhart-King · Cornell University · R01 · FY2015 · HL
Subcellular enzyme-instructed self-assembly for molecular anticancer nanomedicines
$397,052Bing Xu · Brandeis University · R01 · FY2025 · CA
Subcellular enzyme-instructed self-assembly for molecular anticancer nanomedicines
$397,052Bing Xu · Brandeis University · R01 · FY2023 · CA
Systemic delivery of an oncolytic adenovirus targeting TGFβ to enhance anti-PD-1 and anti-CTLA-4 therapy for triple negative breast cancer
$396,958Weidong Xu · Endeavor Health Clinical Operations · R01 · FY2024 · CA
Project 1: Elucidating the genetics and cell of origin of pancreatic cancer initiation
$396,921Laura D Attardi · Stanford University · P01 · FY2024 · CA
Induction of interferon response by chromatin damaging anti-cancer therapy
$396,881Katerina V Gurova · Roswell Park Cancer Institute Corp · R01 · FY2024 · CA
Induction of interferon response by chromatin damaging anti-cancer therapy
$396,881Katerina V Gurova · Roswell Park Cancer Institute Corp · R01 · FY2025 · CA
Mechanical Regulation of Tumor Angiogenesis
$396,871Cynthia A Reinhart-King · Cornell University · R01 · FY2016 · HL
The Role of ADAM15 in Prostate Tumor Intravazation and Metastasis
$396,866Mark L Day · University Of Michigan At Ann Arbor · R01 · FY2011 · CA
Role of Tumor Stem Cells Recurrent Prostate Cancer
$396,862Gary Smith · Univ Of North Carolina Chapel Hill · P01 · FY2012 · CA
Precision nanotherapeutics for cancer treatment
$396,853Jianjun Cheng · University Of Illinois At Urbana-Champaign · R01 · FY2020 · CA
Precision nanotherapeutics for cancer treatment
$396,853Timothy M Fan · University Of Illinois At Urbana-Champaign · R01 · FY2021 · CA
The lymph node microenvionment in tumor metastasis
$396,852Judith A. Varner · University Of California, San Diego · R01 · FY2009 · CA
Molecular mechanism by which Tim-3 induces T cell dysfunction and inhibits anti-t
$396,839Vijay K Kuchroo · Brigham And Women'S Hospital · P01 · FY2017 · AI
Mechanisms and therapeutic targeting of osteoimmune functions of RANKL in breast cancer
$396,834Selvarangan Ponnazhagan · University Of Alabama At Birmingham · R01 · FY2024 · CA
Project 3: Early detection and prevention of MM progression
$396,805Peter Leif Bergsagel · Mayo Clinic Arizona · P50 · FY2021 · CA
Targeting the MUC1-C Oncoprotein in Triple-Negative Breast Cancer
$396,771Donald W. Kufe · Dana-Farber Cancer Inst · R01 · FY2021 · CA